Medication-Assisted Treatment in Pregnancy
This brief outlines some of the barriers that pregnant and postpartum women with opioid use disorder face, as well as examples of state legislation passed to address recovery program implementation, ...
This brief outlines some of the barriers that pregnant and postpartum women with opioid use disorder face, as well as examples of state legislation passed to address recovery program implementation, ...
Opioid and substance use disorders (SUD) continue to affect families beyond pregnancy; in 2017, about one in eight U.S. children lived in a household where at least one parent had a SUD in the prior ...
Substance use disorder (SUD) among pregnant and postpartum women is an increasingly pressing public health concern.
In 2020, the COVID-19 pandemic exacerbated barriers to care and treatment for individuals experiencing opioid use disorder. Experts estimate a record-setting 90,000 people died of a drug overdose in ...
Perinatal substance use is a serious public health issue, resulting in detrimental and even life-threatening fetal outcomes, and it continues to grow.
Support from postpartum doulas can can increase parental self-efficacy and adherence to treatment for those experiencing SUD, leading to lower rates of postpartum depression and, subsequently, ...
This four-part infographic series illustrates key strategies for addressing common challenges and barriers related to increasing access to contraception.